Moracizinum [INN-Latin] en es it fr

Moracizinum [INN-Latin] Brand names, Moracizinum [INN-Latin] Analogs

Moracizinum [INN-Latin] Brand Names Mixture

  • No information avaliable

Moracizinum [INN-Latin] Chemical_Formula


Moracizinum [INN-Latin] RX_link

Moracizinum [INN-Latin] fda sheet

Moracizinum [INN-Latin] msds (material safety sheet)

Moracizinum_[INN-Latin] MSDS

Moracizinum [INN-Latin] Synthesis Reference

No information avaliable

Moracizinum [INN-Latin] Molecular Weight

287.398 g/mol

Moracizinum [INN-Latin] Melting Point

No information avaliable

Moracizinum [INN-Latin] H2O Solubility

No information avaliable

Moracizinum [INN-Latin] State


Moracizinum [INN-Latin] LogP


Moracizinum [INN-Latin] Dosage Forms

Cream; Gel (1%)

Moracizinum [INN-Latin] Indication

For the topical treatment of tinea pedis, tinea cruris, and tinea corporis caused by the organisms Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans and Epidermophyton floccosum.

Moracizinum [INN-Latin] Pharmacology

Naftifine is a synthetic, broad spectrum, antifungal agent and allylamine derivative. The following in vitro data are available, but their clinical significance is unknown. Naftifine has been shown to exhibit fungicidal activity in vitro against a broad spectrum of organisms including Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton tonsurans, Epidermophyton floccosum, and Microsporum canis, Microsporum audouini, and Microsporum gypseum; and fungistatic activity against Candida species including Candida albicans. However it is only used to treat the organisms listed in the indications.

Moracizinum [INN-Latin] Absorption

Following single topical applications of 3H-labeled naftifine gel 1% to the skin of healthy subjects, up to 4.2% of the applied dose was absorbed.

Moracizinum [INN-Latin] side effects and Toxicity

No information avaliable

Moracizinum [INN-Latin] Patient Information

No information avaliable

Moracizinum [INN-Latin] Organisms Affected

Yeast and other fungi